arrow
L

Lin-Quan Tang

Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy
H指数:32
被引数:3,905

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Concurrent chemoradiotherapy plus nimotuzumab versus chemoradiotherapy alone for locoregionally advanced nasopharyngeal carcinoma with a suboptimal response to induction chemotherapy: a randomized phase 2 trial

同步放化疗联合尼莫单抗 versus 放化疗单用治疗对诱导化疗反应欠佳的局部晚期鼻咽癌:一项随机Ⅱ期试验

2026-03-310
OAAI
A selective enrichment and specific probe terminal mediated strategy for highly sensitive detection of microRNAs

一种选择性富集和特异性探针末端介导的高灵敏度miRNA检测策略

2026-03-160
OAAI
Epstein–Barr virus DNA-guided chemoradiotherapy for patients with low-risk locoregionally advanced nasopharyngeal carcinoma: a secondary 5-year follow-up analysis of an open-label, randomised controlled, phase 2 non-inferiority trial

Epstein–Barr病毒DNA指导的化疗放疗用于低危局部区域晚期鼻咽癌患者的治疗:一项开放标签、随机对照、II期非劣效性试验的5年随访二次分析

2025-10-300
OAAI
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China

伊扎龙坦单抗培米替康,一种EGFR和HER3双特异性抗体-药物偶联物,与化疗在重度预治疗复发性或转移性鼻咽癌中的比较:一项在中国进行的多中心、随机、开放标签、III期研究

2025-10-190
PRE
Locoregional Radiotherapy Candidates in de Novo Metastatic Nasopharyngeal Carcinoma: Real-World Insights in the Immunotherapy Era

局部区域放射治疗候选者在原发转移性鼻咽癌中的应用:免疫治疗时代的真实世界洞察

2025-04-010
PRE
Integrative Transcriptome-Wide Association Study With Expression Quantitative Trait Loci Colocalization Identifies a Causal VAMP8 Variant for Nasopharyngeal Carcinoma Susceptibility

整合转录组-wide关联研究与表达数量性状基因座共定位鉴定出一个导致鼻咽癌易感性的VAMP8变异。

2025-01-240
OAAI
Efficacy and safety of cadonilimab in previously treated recurrent or metastatic nasopharyngeal carcinoma(COMPASSION-06): A phase II multicenter study

cadonilimab在先前治疗过的复发或转移性鼻咽癌中的疗效和安全性 (COMPASSION-06): 一项II期多中心研究

2024-04-012
PRE